Pituitary irradiation is ineffective in normalizing plasma insulin-like growth factor I in patients with acromegaly

Journal of Clinical Endocrinology and Metabolism

Volumn 82, Issue 10, 1997, Pages 3187-3191

  Barkan, Ariel L ^a,c   Halasz, Ildiko ^a   Dornfeld, Kenneth J ^b   Jaffe, Craig A ^a   Friberg, Roberta Demott ^a   Chandler, William F ^b   Sandler, Howard M ^b  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^c UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BROMOCRIPTINE; GROWTH HORMONE; OCTREOTIDE; SOMATOMEDIN C;

ACROMEGALY; ADOLESCENT; ADULT; ARTICLE; BRAIN RADIATION; FEMALE; FOLLOW UP; GROWTH HORMONE BLOOD LEVEL; HUMAN; HYPOPHYSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; TREATMENT OUTCOME;

ACROMEGALY; ADOLESCENT; ADULT; AGED; FEMALE; HUMAN GROWTH HORMONE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; MALE; MIDDLE AGED; PITUITARY GLAND; REFERENCE VALUES;

EID: 0030884349     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.82.10.3187     Document Type: Article

References (40)

1. Aloia JF, Roginsky MS, Archambeau JO. 1974 Pituitary irradiation in acromegaly. Am J Med Sci. 267:81-87.
2. Lamberg BA, Kivikangas V, Vartiainen J, Raitta C, Pelkonen R. 1976 Conventional pituitary irradiation in acromegaly. Acta Endocrinol (Copenh). 82:267-281.
3. Feek CM, McLelland J, Seth J, et al. 1984 How effective is external pituitary irradiation for growth hormone-secreting pituitary tumors? Clin Endocrinol (Oxf). 20:401-408.
4. Lam KSL, Wang C, Choi P, Ma JTC, Yeung RTT. 1989 Long-term effects of megavoltage radiotherapy in acromegaly. Aust NZ J Med. 19:202-206.
5. Macleod AF, Clarke DG, Pambakian H, Lowy C, Sonksen PH, Collins CD. 1989 Treatment of acromegaly by external irradiation. Clin Endocrinol (Oxf). 30:303-314.
6. Dowsett RJ, Fowble B, Sergott RC, et al. 1990 Results of radiotherapy in the treatment of acromegaly: lack of ophthalmologic complications. Int J Radiat Oncol Biol Physiol. 19:453-459.
7. Speirs CJ, Reed PI, Morrison R, Aber V, Joplin GF. 1990 The effectiveness of external beam radiotherapy for acromegaly is not affected by previous pituitary ablative treatments. Acta Endocrinol (Copenh). 122:559-565.
8. Gorden P, Glatstein E, Oldfield E, Roth J. 1986 Conventional supervoltage radiation in the treatment of acromegaly. In: Robbins RJ, Melmed S, eds. Acromegaly. New York: Plenum Press; 211-220.
9. Eastman RC, Gorden P, Glatstein E, Roth J. 1992 Radiation therapy of acromegaly. Endocrinol Metab Clin North Am. 21:693-712.
10. Ho PJ, Jaffe CA, DeMoK Friberg R, Barkan AL. 1994 Persistence of rapid GH pulsatility after successful removal of GH producing tumors. J Clin Endocrinol Metab. 78:1403-1410.
11. Clemmons DR, Van Wyk JJ, Ridgway EC, et al. 1979 Evaluation of acromegaly by radioimmunoassay of somatomedin-C. N Engl J Med. 301:1138-1142.
12. Spagnoli A, Rosenfeld RG. 1996 The mechanisms by which growth hormone brings about growth. Endocrinol Metab Clin North Am. 25:615-631.
13. Barkan AL, Kelch RP, Beitins IZ. 1988 Plasma IGF-I/SmC in acromegaly; correlation with the degree of CH hypersecretion. J Clin Endocrinol Metab. 67:69-73.
14. Daughaday WH, Starkey RH, Saltman S, Gavin III JR, Mills-Dunlap B, Heath-Monnig E. 1987 Characterization of serum growth hormone (GH) and insulin-like growth factor I in active acromegaly with minimal elevation of serum GH. J Clin Endocrinol Metab. 65:617-623.
15. Miyazaki R, Yoshida T, Sakane N, et al. 1995 Acromegalic gigantism with low serum level of growth hormone and elevated serum insulin-like growth factor-I. J Intern Med. 34:183-187.
16. Jaffe CA, Barkan AL. 1992 Treatment of acromegaly with dopamine agonists. Endocrinol Metab Clin North Am. 21:713-735.
17. Lamberts SWJ, Reubi J-C, Krenning EP. 1992 Somatostatin analogs in the treatment of acromegaly. Endocrinol Metab Clin North Am. 21:737-752.
18. Acromegaly Therapy Consensus Development Panel. 1994 Consensus statement: benefits versus risks of medical therapy for acromegaly. Am J Med. 97:468-473.
19. Melmed S, Ho K, Klibanski A, Reichlin S, Thorner M. 1995 Recent advances in pathogenesis, diagnosis, and management of acromegaly. J Clin Endocrinol Metab. 80:3395-3402.
20. Lichter AS, Lawrence TS. 1995 Recent advances in radiation oncology. N Engl J Med. 332:371-379.
21. Ciccarelli E, Valett MR, Vasario E, Avataneo T, Grottoli S, Camanni F. 1993 Hormonal and radiological effects of megavoltage radiotherapy in patients with growth hormone-secreting pituitary adenoma. J Endocrinol Invest. 16:565-572.
22. Lindholm J, Giwercman B, Giwercman A, Astrup J, Bjerre P, Skakkebæk NE. 1987 Investigation of the criteria for assessing the outcome of treatment in acromegaly. Clin Endocrinol (Oxf). 27:553-562.
23. Baldwin A, Cundy T, Butler J, Timmis AD. 1985 Progression of cardiovascular disease in acromegalic patients treated by external pituitary irradiation. Acta Endocrinol (Copenh). 108:26-30.
24. Dons RF, Rosselet P, Pastakia B, Doppman J, Gorden P. 1988 Arthropathy in acromegalic patients before and after treatment: a long-term follow-up study. Clin Endocrinol (Oxf). 28:515-524.
25. Bates AS, Van't Hoff W, Jones JM, Clayton RN. 1993 An audit of outcome of treatment in acromegaly. Q J Med. 86:293-299.
26. Rajasoorya C, Holdaway IM, Wrightson P, Scott DJ, Ibbertson HK. 1994 Determinants of clinical outcome and survival in acromegaly. Clin Endocrinol (Oxf). 41:95-102.
27. Ho KKY. 1995 The complications of growth hormone therapy. In: Torosian MH, ed. Growth hormone in critical illness-research and clinical studies. Boston: Landes; 225-246.
28. Rudman D, Kutner MH, Rogers CM, Lubin MF, Fleming A, Bain RP. 1981 Impaired growth hormone secretion in the adult population. J Clin Invest. 67:1361-1369.
29. Yamamoto H, Sohmiya M, Oka N, Kato Y. 1991 Effects of aging and sex on plasma insulin-like growth factor I (IGF-I) levels in normal adults. Acta Endocrinol (Copenh). 124:497-500.
30. Littley MD, Shalet SM, Swindell R, Beardwell CG, Sutton ML. 1990 Low-dose pituitary irradiation for acromegaly. Clin Endocrinol (Oxf). 32:261-270.
31. Kliman B, Kjellberg RN, Swisher B, Butler W. 1986 Long-term effects of proton-beam therapy for acromegaly. In: Robbins RJ, Melmed S, eds. Acromegaly. New York: Plenum Press; 221-228.
32. Lüdecke DK, Lutz BS, Niedworok G. 1989 The choice of treatment after incomplete adenomectomy in acromegaly: proton versus high voltage radiation. Acta Neurochir. 96:32-38.
33. Thorén M, Rähn T, Guo W, Werner S. 1991 Stereotactic radiosurgery with the cobalt-60 gamma unit in the treatment of growth hormone-producing pituitary tumors. Neurosurgery. 29:663-668.
34. Pollock BE, Kondziolka D, Lunsford LD, Flickinger JC. 1994 Stereotactic radiosurgery for pituitary adenomas: imaging, visual and endocrine results. Acta Neurochir. 62(Suppl):33-38.
35. 90Y pituitary implantation in acromegaly. Acta Endocrinol (Copenh). 115:301-306.
36. Caron P, Morange-Ramos I, Cogne I, Jaquet P. 1997 Three year follow-up of acromegalic patients treated with intramuscular slow-release lanreotide. J Clin Endocrinol Metab. 82:18-22.
37. Kvistborg Fløgstad A, Halse J, Bakke S, et al. 1997 Sandostatin LAR in acromegalic patients: long term treatment. J Clin Endocrinol Metab. 81:23-28.
38. Werner S, Trampe E, Palacios P, Lax I, Hall K. 1985 Growth hormone producing pituitary adenomas with concomitant hypersecretion of prolactin are particularly sensitive to photon irradiation. Int J Radiat Oncol Biol Physiol. 11:1713-1720.
39. Kovalic JJ, Mazoujian G, McKeel DW, Fineberg BB, Grigsby PW. 1993 Immunohistochemistry as a predictor of clinical outcome in patients given postoperative radiation for subtotally resected pituitary adenomas. J Neurooncol. 16:227-232.
40. Newman CB, Melmed S, Snyder PJ, et al. 1995 Safety and efficacy of long term octreotide therapy of acromegaly: results of a multicenter trial in 103 patients - a clinical research center study. J Clin Endocrinol Metab. 80:2768-2775.